-
Teva Pharmaceutical in Recovery -
-
Teva U.S. on Price-Fixing Charges WSJ
-
Teva $523 million deal to settle lawsuit New York | CNN Business
-
Teva Foreign Corruption Probe for $519 - WSJ
-
Teva Pharmaceutical's Stock Outlook WSJ
-
charged US price-fixing investigation Financial Times
-
Teva Pharmaceutical's Stock Outlook WSJ
-
shares surge after announcing global settlement
-
Teva's Opioid Settlement Isn't in the Yet -
-
Teva Pharmaceutical's Stock Outlook WSJ
-
Teva U.S. on Price-Fixing Charges WSJ
-
TEVA Beats on Q1 and Sales, Keeps View, Stock Down
-
Parsippany-based Teva reaches opioid settlement with Texas - NJBIZ
-
Teva shares hit 19-year low opioid settlement, analyst | Fierce
-
Teva Pharmaceutical's Stock Outlook WSJ
-
Teva Agrees to Settle Opioid Lawsuits as Much as $4.25 Billion - WSJ
-
shares surge after announcing global settlement
-
Teva Pharmaceutical's Stock Outlook WSJ
-
Teva Crashes Following Purdue $10-$12 Settlement | Ctech
-
Teva Pharmaceuticals found liable New York opioid trial - BBC News
-
Teva Pharmaceutical's Stock Outlook WSJ
-
Teva Pharmaceutical to Replace Kare Schultz - WSJ
-
Teva Agrees to Settle Opioid Lawsuits as Much as $4.25 Billion - WSJ
-
Teva seeks CEO replacement Shultz will retire in 2023: WSJ
-
Teva Pharmaceutical's Stock Outlook WSJ